919-30-2 | 3-Aminopropyltriethoxysilane

Chemical type

• Organosilane coupling agent
• Amino-functional silane

^[1]

• Silane coupling agent

^[2]

• Surface modifier

^[3]

Key properties

• Contains amino (-NH2) and ethoxysilane groups for polymerization
• Controls nanosphere size in TAP NPs synthesis
• Forms Si-O-Si networks and -C=N bonds
• Concentration 0.6-2.1 mg/mL tunes properties

^[1]

• Contains amino (–NH₂) groups
• Hydrolyzes to form Si–OH groups under acidic conditions
• Chemically grafts onto silica surfaces

^[2]

• Forms stable Si–O–Fe bonds on magnetite surface; introduces hydrophilic –NH₂/–NH₃⁺ groups; enables covalent (imine) and electrostatic drug binding; confers biocompatibility and prevents agglomeration/oxidation of bare MNPs

^[3]

• Reactant with TA to form TAP NPs in ethanol-Tris-HCl solution
• Provides reactive sites for hydrogen bonding with F127-F
• Adjusts physical topology for membrane roughness and superoleophobicity

^[1]

• Surface modifier for silica aerogels to enhance dispersion in polymer matrices
• Improves interfacial adhesion via hydrogen bonding

^[2]

• Surface functionalisation of magnetite nanoparticles to create a stable, biocompatible nanocarrier (APTES@MNPs) that supports high drug loading (up to 99 % at pH ~10) and controlled release

^[3]

Classification by use

• Chemicals used in nanomaterial synthesis
• Chemicals for crosslinking and surface engineering

^[1]

• Chemicals used as coupling agents
• Chemicals used in surface modification

^[2]

A trustworthy factory and manufacturer

1. [Cite:1] Construction of dual-heterogeneous membrane surface via nanosphere-mediated surface segregation for oil-water separation, Advanced Membranes, Volume 7, June 2026, 100205
2. [Cite:2] Preparation and Performance of Thermal Insulation Waterborne Polyurethane Coatings Containing 3-Aminopropyltriethoxysilane Modified Organo-Bridged Silica Aerogel, Coatings, 2025, 15(9), 1021
3. [Cite:3] APTES modified magnetite nanoparticles as a theranostic nanocarrier: a study of loading and sustained release of daunorubicin, Mater. Adv., 2025,6, 6843-6855